$PMC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PharMerica CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PharMerica CORP. Get notifications about new insider transactions in PharMerica CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 15 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 20.55 | 33,515 | 688,733 | 44,969 | 78.5 K to 45 K (-42.70 %) |
Nov 15 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Buy | M | 16.31 | 38,563 | 628,963 | 78,484 | 39.9 K to 78.5 K (+96.60 %) |
Nov 15 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 16.75 | 67,481 | 1,130,307 | 0 | |
Nov 15 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 20.25 | 60,081 | 1,216,640 | 71,259 | 131.3 K to 71.3 K (-45.74 %) |
Nov 15 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 16.75 | 67,481 | 1,130,307 | 131,340 | 63.9 K to 131.3 K (+105.67 %) |
Oct 01 2013 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 13.03 | 788 | 10,268 | 20,534 | 21.3 K to 20.5 K (-3.70 %) |
Aug 02 2013 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
Jun 19 2013 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Grant | A | 0.00 | 5,685 | 0 | 40,244 | 34.6 K to 40.2 K (+16.45 %) |
Jun 19 2013 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Grant | A | 0.00 | 5,685 | 0 | 33,954 | 28.3 K to 34 K (+20.11 %) |
Jun 19 2013 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Grant | A | 0.00 | 5,685 | 0 | 40,244 | 34.6 K to 40.2 K (+16.45 %) |
Jun 19 2013 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Grant | A | 0.00 | 5,685 | 0 | 35,339 | 29.7 K to 35.3 K (+19.17 %) |
Jun 19 2013 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 5,685 | 0 | 34,189 | 28.5 K to 34.2 K (+19.94 %) |
Jun 19 2013 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 5,685 | 0 | 52,244 | 46.6 K to 52.2 K (+12.21 %) |
Jun 19 2013 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Grant | A | 0.00 | 5,685 | 0 | 30,607 | 24.9 K to 30.6 K (+22.81 %) |
Jun 19 2013 | PMC | PharMerica CORP | LEPORE PATRICK G | Director | Grant | A | 0.00 | 5,685 | 0 | 11,685 | 6 K to 11.7 K (+94.75 %) |
Jun 14 2013 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Payment of Exercise | F | 15.50 | 3,300 | 51,150 | 28,504 | 31.8 K to 28.5 K (-10.38 %) |
May 31 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | M | 10.84 | 5,926 | 64,238 | 5,928 | |
May 31 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.68 | 9,724 | 152,497 | 10,263 | 20 K to 10.3 K (-48.65 %) |
May 31 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Buy | M | 10.84 | 5,926 | 64,238 | 19,987 | 14.1 K to 20 K (+42.14 %) |
Mar 27 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 14.03 | 10,198 | 143,078 | 652,454 | 662.7 K to 652.5 K (-1.54 %) |
Mar 27 2013 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Payment of Exercise | F | 14.03 | 836 | 11,729 | 21,651 | 22.5 K to 21.7 K (-3.72 %) |
Mar 27 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 14.03 | 464 | 6,510 | 14,061 | 14.5 K to 14.1 K (-3.19 %) |
Mar 27 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 14.03 | 1,321 | 18,534 | 60,291 | 61.6 K to 60.3 K (-2.14 %) |
Mar 27 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 14.03 | 824 | 11,561 | 39,921 | 40.7 K to 39.9 K (-2.02 %) |
Mar 27 2013 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Payment of Exercise | F | 14.03 | 2,843 | 39,887 | 183,369 | 186.2 K to 183.4 K (-1.53 %) |
Mar 27 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 14.03 | 1,548 | 21,718 | 63,859 | 65.4 K to 63.9 K (-2.37 %) |
Mar 06 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 14.48 | 1,058 | 15,320 | 40,745 | 41.8 K to 40.7 K (-2.53 %) |
Mar 06 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Grant | A | 0.00 | 2,967 | 0 | 41,803 | 38.8 K to 41.8 K (+7.64 %) |
Mar 06 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Grant | A | 0.00 | 8,461 | 0 | 38,836 | 30.4 K to 38.8 K (+27.86 %) |
Mar 06 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 14.48 | 7,984 | 115,608 | 662,652 | 670.6 K to 662.7 K (-1.19 %) |
Mar 06 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 22,217 | 0 | 670,636 | 648.4 K to 670.6 K (+3.43 %) |
Mar 06 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 66,377 | 0 | 648,419 | 582 K to 648.4 K (+11.40 %) |
Mar 06 2013 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Payment of Exercise | F | 14.48 | 3,181 | 46,061 | 186,212 | 189.4 K to 186.2 K (-1.68 %) |
Mar 06 2013 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Grant | A | 0.00 | 8,917 | 0 | 189,393 | 180.5 K to 189.4 K (+4.94 %) |
Mar 06 2013 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Grant | A | 0.00 | 26,597 | 0 | 180,476 | 153.9 K to 180.5 K (+17.28 %) |
Mar 06 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 14.48 | 1,727 | 25,007 | 61,612 | 63.3 K to 61.6 K (-2.73 %) |
Mar 06 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Grant | A | 0.00 | 4,756 | 0 | 63,339 | 58.6 K to 63.3 K (+8.12 %) |
Mar 06 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Grant | A | 0.00 | 11,405 | 0 | 58,583 | 47.2 K to 58.6 K (+24.17 %) |
Mar 06 2013 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Grant | A | 0.00 | 7,925 | 0 | 22,487 | 14.6 K to 22.5 K (+54.42 %) |
Mar 06 2013 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Grant | A | 0.00 | 6,371 | 0 | 20,614 | 14.2 K to 20.6 K (+44.73 %) |
Mar 06 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 14.48 | 2,058 | 29,800 | 65,407 | 67.5 K to 65.4 K (-3.05 %) |
Mar 06 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 5,630 | 0 | 67,465 | 61.8 K to 67.5 K (+9.10 %) |
Mar 06 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 15,023 | 0 | 61,835 | 46.8 K to 61.8 K (+32.09 %) |
Mar 06 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 14.48 | 702 | 10,165 | 14,525 | 15.2 K to 14.5 K (-4.61 %) |
Mar 06 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 1,723 | 0 | 15,227 | 13.5 K to 15.2 K (+12.76 %) |
Mar 06 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 4,368 | 0 | 13,504 | 9.1 K to 13.5 K (+47.81 %) |
Mar 05 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 14.56 | 1,671 | 24,330 | 47,178 | 48.8 K to 47.2 K (-3.42 %) |
Mar 05 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 14.56 | 1,453 | 21,156 | 30,375 | 31.8 K to 30.4 K (-4.57 %) |
Mar 05 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 14.56 | 1,972 | 28,712 | 46,812 | 48.8 K to 46.8 K (-4.04 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | M | 13.47 | 3,915 | 52,735 | 0 | |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.18 | 100 | 1,518 | 9,136 | 9.2 K to 9.1 K (-1.08 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.17 | 1,900 | 28,823 | 9,236 | 11.1 K to 9.2 K (-17.06 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.16 | 200 | 3,032 | 11,136 | 11.3 K to 11.1 K (-1.76 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.15 | 100 | 1,515 | 11,336 | 11.4 K to 11.3 K (-0.87 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.15 | 400 | 6,060 | 11,436 | 11.8 K to 11.4 K (-3.38 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.15 | 215 | 3,257 | 11,836 | 12.1 K to 11.8 K (-1.78 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.13 | 400 | 6,052 | 12,051 | 12.5 K to 12.1 K (-3.21 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 15.13 | 600 | 9,078 | 12,451 | 13.1 K to 12.5 K (-4.60 %) |
Feb 14 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Buy | M | 13.47 | 3,915 | 52,735 | 13,051 | 9.1 K to 13.1 K (+42.85 %) |
Jan 23 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 15.00 | 10,350 | 155,250 | 582,042 | 592.4 K to 582 K (-1.75 %) |
Jan 23 2013 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Payment of Exercise | F | 15.00 | 1,382 | 20,730 | 14,562 | 15.9 K to 14.6 K (-8.67 %) |
Jan 23 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 15.00 | 742 | 11,130 | 9,136 | 9.9 K to 9.1 K (-7.51 %) |
Jan 23 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 15.00 | 1,504 | 22,560 | 31,828 | 33.3 K to 31.8 K (-4.51 %) |
Jan 23 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 15.00 | 2,027 | 30,405 | 48,849 | 50.9 K to 48.8 K (-3.98 %) |
Jan 23 2013 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 15.00 | 2,671 | 40,065 | 48,784 | 51.5 K to 48.8 K (-5.19 %) |
Jan 23 2013 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Payment of Exercise | F | 15.00 | 4,329 | 64,935 | 153,879 | 158.2 K to 153.9 K (-2.74 %) |
Jan 14 2013 | PMC | PharMerica CORP | LEPORE PATRICK G | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Sep 27 2012 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Grant | A | 0.00 | 7,782 | 0 | 7,782 | 0 to 7.8 K |
Sep 27 2012 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Sell | D | 12.68 | 2,500 | 31,700 | 31,804 | 34.3 K to 31.8 K (-7.29 %) |
Jun 15 2012 | PMC | PharMerica CORP | Monast William E | EVP | Buy | P | 9.60 | 5,000 | 47,986 | 47,010 | 42 K to 47 K (+11.90 %) |
Jun 15 2012 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 9.36 | 500 | 4,679 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
Jun 15 2012 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 9.37 | 4,000 | 37,468 | 7,000 | 3 K to 7 K (+133.33 %) |
Jun 15 2012 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 9.48 | 31,000 | 293,896 | 592,392 | 561.4 K to 592.4 K (+5.52 %) |
Jun 15 2012 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Buy | P | 9.51 | 15,000 | 142,632 | 158,208 | 143.2 K to 158.2 K (+10.47 %) |
Jun 13 2012 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Grant | A | 0.00 | 9,657 | 0 | 28,269 | 18.6 K to 28.3 K (+51.89 %) |
Jun 13 2012 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Grant | A | 0.00 | 9,657 | 0 | 24,922 | 15.3 K to 24.9 K (+63.26 %) |
Jun 13 2012 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 9,657 | 0 | 34,304 | 24.6 K to 34.3 K (+39.18 %) |
Jun 13 2012 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 9,657 | 0 | 46,559 | 36.9 K to 46.6 K (+26.17 %) |
Jun 13 2012 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Grant | A | 0.00 | 9,657 | 0 | 34,559 | 24.9 K to 34.6 K (+38.78 %) |
Jun 13 2012 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Grant | A | 0.00 | 9,657 | 0 | 29,654 | 20 K to 29.7 K (+48.29 %) |
Jun 13 2012 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Grant | A | 0.00 | 9,657 | 0 | 34,559 | 24.9 K to 34.6 K (+38.78 %) |
Mar 28 2012 | PMC | PharMerica CORP | Monast William E | EVP | Payment of Exercise | F | 12.44 | 2,137 | 26,584 | 42,010 | 44.1 K to 42 K (-4.84 %) |
Mar 28 2012 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Payment of Exercise | F | 12.44 | 816 | 10,151 | 15,944 | 16.8 K to 15.9 K (-4.87 %) |
Mar 28 2012 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 12.44 | 453 | 5,635 | 9,878 | 10.3 K to 9.9 K (-4.38 %) |
Mar 28 2012 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 12.44 | 1,289 | 16,035 | 50,876 | 52.2 K to 50.9 K (-2.47 %) |
Mar 28 2012 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 12.44 | 804 | 10,002 | 33,332 | 34.1 K to 33.3 K (-2.36 %) |
Mar 28 2012 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Payment of Exercise | F | 12.44 | 2,771 | 34,471 | 143,208 | 146 K to 143.2 K (-1.90 %) |
Mar 28 2012 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 12.44 | 1,510 | 18,784 | 51,455 | 53 K to 51.5 K (-2.85 %) |
Mar 01 2012 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 12.29 | 2,010 | 24,703 | 561,392 | 559.4 K to 561.4 K (+0.36 %) |
Mar 01 2012 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 12.30 | 17,990 | 221,277 | 559,382 | 541.4 K to 559.4 K (+3.32 %) |
Jan 20 2012 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 5,456 | 0 | 10,331 | 4.9 K to 10.3 K (+111.92 %) |
Jan 20 2012 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 84,558 | 0 | 541,392 | 456.8 K to 541.4 K (+18.51 %) |
Jan 20 2012 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Grant | A | 0.00 | 9,898 | 0 | 16,760 | 6.9 K to 16.8 K (+144.24 %) |
Jan 20 2012 | PMC | PharMerica CORP | Monast William E | EVP | Grant | A | 0.00 | 25,885 | 0 | 44,147 | 18.3 K to 44.1 K (+141.74 %) |
Jan 20 2012 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Grant | A | 0.00 | 14,529 | 0 | 52,165 | 37.6 K to 52.2 K (+38.60 %) |
Jan 20 2012 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Grant | A | 0.00 | 10,779 | 0 | 34,136 | 23.4 K to 34.1 K (+46.15 %) |
Jan 20 2012 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Grant | A | 0.00 | 33,882 | 0 | 145,979 | 112.1 K to 146 K (+30.23 %) |
Jan 20 2012 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 19,138 | 0 | 52,965 | 33.8 K to 53 K (+56.58 %) |
Nov 21 2011 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 15.33 | 1,932 | 29,618 | 37,636 | 39.6 K to 37.6 K (-4.88 %) |
Nov 21 2011 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 15.33 | 1,183 | 18,135 | 23,357 | 24.5 K to 23.4 K (-4.82 %) |
Nov 21 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 15.33 | 2,074 | 31,794 | 33,827 | 35.9 K to 33.8 K (-5.78 %) |
Jun 13 2011 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 7,273 | 0 | 24,647 | 17.4 K to 24.6 K (+41.86 %) |
Jun 13 2011 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 7,273 | 0 | 36,902 | 29.6 K to 36.9 K (+24.55 %) |
Jun 13 2011 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Grant | A | 0.00 | 7,273 | 0 | 15,265 | 8 K to 15.3 K (+91.00 %) |
Jun 13 2011 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Grant | A | 0.00 | 7,273 | 0 | 24,902 | 17.6 K to 24.9 K (+41.26 %) |
Jun 13 2011 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Grant | A | 0.00 | 7,273 | 0 | 18,612 | 11.3 K to 18.6 K (+64.14 %) |
Jun 13 2011 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Grant | A | 0.00 | 7,273 | 0 | 19,997 | 12.7 K to 20 K (+57.16 %) |
Jun 13 2011 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Grant | A | 0.00 | 7,273 | 0 | 24,902 | 17.6 K to 24.9 K (+41.26 %) |
Apr 01 2011 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Option Exercise | A | 10.84 | 72,178 | 782,410 | 72,178 | |
Apr 01 2011 | PMC | PharMerica CORP | CULOTTA MICHAEL J | EVP and CFO | Grant | A | 0.00 | 23,904 | 0 | 112,097 | 88.2 K to 112.1 K (+27.10 %) |
Apr 01 2011 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | A | 10.84 | 11,854 | 128,497 | 11,854 | |
Apr 01 2011 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 3,926 | 0 | 4,875 | 949 to 4.9 K (+413.70 %) |
Apr 01 2011 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Option Exercise | A | 10.84 | 20,418 | 221,331 | 20,418 | |
Apr 01 2011 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Grant | A | 0.00 | 6,762 | 0 | 24,540 | 17.8 K to 24.5 K (+38.04 %) |
Apr 01 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 10.84 | 38,352 | 415,736 | 38,352 | |
Apr 01 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 12,701 | 0 | 35,901 | 23.2 K to 35.9 K (+54.75 %) |
Apr 01 2011 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Option Exercise | A | 10.84 | 32,729 | 354,782 | 32,729 | |
Apr 01 2011 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Grant | A | 0.00 | 10,839 | 0 | 39,568 | 28.7 K to 39.6 K (+37.73 %) |
Apr 01 2011 | PMC | PharMerica CORP | Monast William E | EVP | Option Exercise | A | 10.84 | 55,141 | 597,728 | 55,141 | |
Apr 01 2011 | PMC | PharMerica CORP | Monast William E | EVP | Grant | A | 0.00 | 18,262 | 0 | 18,262 | 0 to 18.3 K |
Apr 01 2011 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Option Exercise | A | 10.84 | 20,719 | 224,594 | 20,719 | |
Apr 01 2011 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Grant | A | 0.00 | 6,862 | 0 | 6,862 | 0 to 6.9 K |
Apr 01 2011 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | A | 10.84 | 182,801 | 1,981,563 | 182,801 | |
Apr 01 2011 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 60,540 | 0 | 456,834 | 396.3 K to 456.8 K (+15.28 %) |
Apr 01 2011 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Grant | A | 0.00 | 7,029 | 0 | 28,729 | 21.7 K to 28.7 K (+32.39 %) |
Apr 01 2011 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 8,237 | 0 | 23,200 | 15 K to 23.2 K (+55.05 %) |
Apr 01 2011 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Grant | A | 0.00 | 5,701 | 0 | 17,778 | 12.1 K to 17.8 K (+47.21 %) |
Mar 18 2011 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 11.18 | 1,200 | 13,417 | 949 | 2.1 K to 949 (-55.84 %) |
Mar 18 2011 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 11.18 | 100 | 1,118 | 2,149 | 2.2 K to 2.1 K (-4.45 %) |
Mar 18 2011 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 11.18 | 1,682 | 18,811 | 2,249 | 3.9 K to 2.2 K (-42.79 %) |
Dec 06 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 11.20 | 600 | 6,720 | 14,963 | 15.6 K to 15 K (-3.86 %) |
Dec 06 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 11.20 | 900 | 10,081 | 15,563 | 16.5 K to 15.6 K (-5.47 %) |
Nov 19 2010 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 11.07 | 1,931 | 21,376 | 21,700 | 23.6 K to 21.7 K (-8.17 %) |
Nov 19 2010 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Payment of Exercise | F | 11.07 | 1,183 | 13,096 | 12,077 | 13.3 K to 12.1 K (-8.92 %) |
Nov 19 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 11.07 | 2,074 | 22,959 | 16,463 | 18.5 K to 16.5 K (-11.19 %) |
Sep 07 2010 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Buy | P | 8.83 | 2,800 | 24,720 | 13,260 | 10.5 K to 13.3 K (+26.77 %) |
Sep 03 2010 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Buy | P | 8.64 | 7,000 | 60,473 | 23,631 | 16.6 K to 23.6 K (+42.09 %) |
Sep 01 2010 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Buy | P | 7.95 | 12,000 | 95,388 | 29,629 | 17.6 K to 29.6 K (+68.07 %) |
Aug 25 2010 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 7.27 | 3,826 | 27,815 | 18,537 | 22.4 K to 18.5 K (-17.11 %) |
Aug 18 2010 | PMC | PharMerica CORP | Monast William E | EVP | Buy | P | 7.49 | 3,500 | 26,214 | 10,000 | 6.5 K to 10 K (+53.85 %) |
Aug 17 2010 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 7.70 | 3,000 | 23,097 | 17,374 | 14.4 K to 17.4 K (+20.87 %) |
Aug 13 2010 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 7.68 | 77,000 | 591,622 | 396,294 | 319.3 K to 396.3 K (+24.12 %) |
Aug 13 2010 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 7.65 | 800 | 6,120 | 3,000 | 2.2 K to 3 K (+36.36 %) |
Aug 13 2010 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 7.64 | 1,800 | 13,752 | 2,200 | 400 to 2.2 K (+450.00 %) |
Aug 13 2010 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 7.63 | 400 | 3,052 | 400 | 0 to 400 |
Aug 13 2010 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | P | 7.65 | 1,000 | 7,650 | 1,000 | 0 to 1,000 |
Aug 12 2010 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Sell | S | 8.20 | 2,305 | 18,901 | 10,460 | 12.8 K to 10.5 K (-18.06 %) |
Aug 12 2010 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Sell | S | 8.20 | 3,865 | 31,693 | 16,631 | 20.5 K to 16.6 K (-18.86 %) |
Aug 12 2010 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Sell | S | 8.40 | 300 | 2,520 | 20,496 | 20.8 K to 20.5 K (-1.44 %) |
May 28 2010 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 4,893 | 0 | 14,374 | 9.5 K to 14.4 K (+51.61 %) |